The Neuroprotection Effect of Dexmedetomidine

• Status: Unknown status
• Trial end date: 2021-02-28
• Target enrollment: 0
• Participant gender: All

Summary

The brain protection effect of dexmedetomidine has been approved in several studies.

Basically, the anti-inflammatory effects and reducing catecholamines are thought to be a main role of the protection effect. In many studies reported the advantage of dexmedetomidine as a substitution of other sedative drugs for anesthesia.

The anesthesia of intra-cranial aneurysmal clipping operation commonly use intravenous anesthetic agents combined with inhalation anesthesia for neuroprotection, and mostly propofol is used.

The aim of this study is to examine the effects of dexmedetomidine on serum inflammatory markers and research the hemodynamic stability of dexmedetomidine compared to propofol in aneurysmal clipping operation.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ajou University School of Medicine
• Treatments: Dexmedetomidine; Propofol

Criteria

Inclusion Criteria:

• ASA class I,II patient needs operation of intracranial aneurysmal clipping without SAH

Exclusion Criteria:

• Any history of neurologic disease, dementia

• Allergic history of propofol or dexmedetomidine